BFM
BLUE

Boothbay Fund Management’s bluebird bio BLUE Stock Holding History

Boothbay Fund Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4
Closed -$459K – 853
2019
Q3 		$459K Sell
4
-26
-87% -$39.7K 0.04% 480
2019
Q2 		$4.92M Buy
30
+15
+100% +$25.9K 0.45% 38
2019
Q1 		$3.04M Hold
15
– – 0.29% 76
2018
Q4 		$1.94M Sell
15
-4
-21% -$6.14K 0.28% 69
2018
Q3 		$3.67M Sell
19
-10
-34% -$20.7K 0.36% 58
2018
Q2 		$5.87M Buy
29
+23
+383% +$52.4K 0.51% 43
2018
Q1 		$1.38M Buy
+6
New +$15.3K 0.16% 127
2016
Q4 		– Sell
-247
Closed -$217K – 765
2016
Q3 		$217K Buy
+247
New +$179K 0.05% 524

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Boothbay Fund Management's BLUE Position: Q3 2023 in Review

Boothbay Fund Management sold out of bluebird bio (BLUE) in Q3 2023, closing a stake of 3,621 shares — an estimated $238K sold.

Boothbay Fund Management first reported a position in BLUE in Q4 2018 and held it in 7 quarters. The position peaked at $987K in Q4 2022. 168 funds tracked by Wall St. Rank hold BLUE as of Q3 2023.

  • Boothbay Fund Management reported no remaining bluebird bio position as of Q3 2023 after selling out during the quarter.
  • Boothbay Fund Management sold 3,621 bluebird bio shares in Q3 2023, an estimated $238K.
  • Boothbay Fund Management first reported a position in bluebird bio in Q4 2018 and held it in 7 quarters.
  • Boothbay Fund Management's bluebird bio position peaked at $987K in Q4 2022.
  • 168 funds tracked by Wall St. Rank held bluebird bio as of Q3 2023.

Based on Boothbay Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.